At the beginning of the Q/A session, the CEO revealed that the general acceptance of Augment usage in Australia after one year since launch has been significantly higher than was expected. I think he said three times better growth than was initially anticipated.
He did and that is a positive as it is being used and liked by the doctors that use it it appears. He also said they are, "...very optimistic that approvable letter is coming" and 'an approvable letter is expected between now and January not pure approval'. So, basically he is still as confident as ever and sticking to the now to January guideline for FDA decision. He said they are ready to launch upon FDA clearance.
Its possible if we don't hear anything this week that it could be in January as there may have been another 'back and forth' informal FDA questions and replies that they did not disclose (they don't have to). BMTI only disclosed them in February as it was a material event in that the company was being sold so in the interest of full disclosure.
Regarding the price action at 4pm it was a very small amount of shares traded and looked like someone was trying to trigger AH stop losses and no one took the bait!